{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:07:06Z","timestamp":1763075226354,"version":"3.45.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Brain atrophy is well documented in various kinds of dementia, particularly in Alzheimer\u2019s disease. Here, we evaluated gray matter volume of 87 cortical and subcortical areas in 460 individuals characterized according to the Clinical Dementia Rating (CDR) as cognitively unimpaired (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009352), undetermined (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200972), or mild dementia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200936). We found a highly significant correspondence between increased dementia severity and reduced brain volume, particularly for the amygdala and temporal cortical areas, including the hippocampus, middle temporal gyrus, and inferior temporal gyrus. The negative correlation between brain volumes and dementia severity was significantly stronger in men than women, and in apolipoprotein E4 carriers than non-carriers. Brain volumes discriminated between cognitively unimpaired and mild dementia cases with high accuracy; application of those classification functions to the undetermined group resulted in two distinct groups, one resembling the cognitively unimpaired Control group and another resembling the Dementia group. These findings highlight the correspondence between clinical dementia stages and objective brain volume measures, and point to the potential clinical utility of adjunctive structural brain measures to identify individuals with memory complaints who may be at risk of dementia.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-23418-9","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:30:38Z","timestamp":1763073038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain volumes discriminate clinical dementia rating scale categories"],"prefix":"10.1038","volume":"15","author":[{"given":"Peka","family":"Christova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos P.","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"23418_CR1","unstructured":"World Health Organization. Dementia Fact Sheet. Website: (2025). https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/dementia. 31 March 2025 (Accessed 17 April 2025)."},{"key":"23418_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan, K. B. et al. Population estimate of people with clinical AD and mild cognitive impairment in the united States (2020\u20132060). Alzheimers Dement. 17, 1966\u20131975 (2021).","journal-title":"Alzheimers Dement."},{"key":"23418_CR3","unstructured":"Alzheimer\u2019s, A. 2024 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement. (2024). https:\/\/bit.ly\/3k6pFW4"},{"key":"23418_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s43587-023-00404-2","volume":"3","author":"WM van der Flier","year":"2023","unstructured":"van der Flier, W. M., de Vugt, M. E., Smets, E. M. A., Blom, M. & Teunissen, C. E. Towards a future where alzheimer\u2019s disease pathology is stopped before the onset of dementia. Nat. Aging. 3, 494\u2013505 (2023).","journal-title":"Nat. Aging"},{"key":"23418_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois, B. et al. Preclinical alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 12, 292\u2013323 (2016).","journal-title":"Alzheimers Dement."},{"key":"23418_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000354370","volume":"3","author":"A Ward","year":"2013","unstructured":"Ward, A., Tardiff, S., Dye, C. & Arrighi, H. M. Rate of conversion from prodromal alzheimer\u2019s disease to alzheimer\u2019s dementia: a systematic review of the literature. Dement. Geriatr. Cogn. Dis. Extra. 3, 320\u2013332 (2013).","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"23418_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini, L. et al. Brain atrophy in alzheimer\u2019s disease and aging. Ageing Res. Rev. 30, 25\u201348 (2016).","journal-title":"Ageing Res. Rev."},{"key":"23418_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuroimage.2013.02.059","volume":"76","author":"A Bakkour","year":"2013","unstructured":"Bakkour, A., Morris, J. C., Wolk, D. A. & Dickerson, B. C. The effects of aging and alzheimer\u2019s disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage 76, 332\u2013344 (2013).","journal-title":"Neuroimage"},{"key":"23418_CR9","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","volume":"29","author":"AM Fjell","year":"2009","unstructured":"Fjell, A. M. et al. One-year brain atrophy evident in healthy aging. J. Neurosci. 29, 15223\u201315231 (2009).","journal-title":"J. Neurosci."},{"key":"23418_CR10","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/brain\/awm112","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell, J. L. et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to alzheimer\u2019s disease. Brain 130, 1777\u20131786 (2007).","journal-title":"Brain"},{"key":"23418_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1212\/01.wnl.0000280575.77437.a2","volume":"70","author":"JL Whitwell","year":"2008","unstructured":"Whitwell, J. L. et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70, 512\u2013520 (2008).","journal-title":"Neurology"},{"key":"23418_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12640-010-9175-1","volume":"18","author":"JL Whitwell","year":"2010","unstructured":"Whitwell, J. L. Progression of atrophy in alzheimer\u2019s disease and related disorders. Neurotox. Res. 18, 339\u2013346 (2010).","journal-title":"Neurotox. Res."},{"key":"23418_CR13","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack","year":"2010","unstructured":"Jack, C. R. et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to alzheimer\u2019s disease. Brain 133, 3336\u20133348 (2010).","journal-title":"Brain"},{"key":"23418_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00415-010-5872-1","volume":"258","author":"JH Roh","year":"2011","unstructured":"Roh, J. H. et al. Volume reduction in subcortical regions according to severity of alzheimer\u2019s disease. J. Neurol. 258, 1013\u20131020 (2011).","journal-title":"J. Neurol."},{"key":"23418_CR15","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/archneur.63.10.1434","volume":"63","author":"J Barnes","year":"2006","unstructured":"Barnes, J. et al. Measurements of the amygdala and hippocampus in pathologically confirmed alzheimer disease and frontotemporal Lobar degeneration. Arch. Neurol. 63, 1434\u20131439 (2006).","journal-title":"Arch. Neurol."},{"key":"23418_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/JAD-150473","volume":"48","author":"S Hilal","year":"2015","unstructured":"Hilal, S. et al. Subcortical atrophy in cognitive impairment and dementia. J. Alzheimers Dis. 48, 813\u2013823 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"23418_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3233\/JAD-201116","volume":"79","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. Altered neuroanatomical asymmetries of subcortical structures in subjective cognitive decline, amnestic mild cognitive impairment, and alzheimer\u2019s disease. J. Alzheimers Dis. 79, 1121\u20131132 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"23418_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","volume":"71","author":"JL Whitwell","year":"2008","unstructured":"Whitwell, J. L. et al. MRI correlates of neurofibrillary tangle pathology at autopsy. Neurology 71, 743\u2013749 (2008).","journal-title":"Neurology"},{"key":"23418_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0306-4522(99)00476-5","volume":"95","author":"M Bobinski","year":"1999","unstructured":"Bobinski, M. et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in alzheimer\u2019s disease. Neuroscience 95, 721\u2013725 (1999).","journal-title":"Neuroscience"},{"key":"23418_CR20","doi-asserted-by":"crossref","unstructured":"Braak, H., Braak, E., Bohl, J. & Bratzke, H. Evolution of Alzheimer\u2019s disease related cortical lesions. in Alzheimer\u2019s Disease \u2014 From Basic Research to Clinical Applications (eds. Gertz, H.-J. & Arendt, Th.) 97\u2013106Springer, Vienna, (1998).","DOI":"10.1007\/978-3-7091-7508-8_9"},{"key":"23418_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/wnl.58.5.750","volume":"58","author":"CR Jack","year":"2002","unstructured":"Jack, C. R. et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58, 750\u2013757. https:\/\/doi.org\/10.1212\/wnl.58.5.750 (2002).","journal-title":"Neurology"},{"key":"23418_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1212\/WNL.52.8.1687","volume":"52","author":"NC Fox","year":"1999","unstructured":"Fox, N. C., Scahill, R. I., Crum, W. R. & Rossor, M. N. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52, 1687\u20131687 (1999).","journal-title":"Neurology"},{"key":"23418_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P. & Thompson, P. M. The clinical use of structural MRI in alzheimer disease. Nat. Rev. Neurol. 6, 67\u201377. https:\/\/doi.org\/10.1038\/nrneurol.2009.215 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"23418_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.2482070938","volume":"248","author":"JD Sluimer","year":"2008","unstructured":"Sluimer, J. D. et al. Whole-Brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 248, 590\u2013598 (2008).","journal-title":"Radiology"},{"key":"23418_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"23418_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/WAD.0b013e31811ff2b4","volume":"21","author":"ML Fagundes Chaves","year":"2007","unstructured":"Fagundes Chaves, M. L. et al. Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis. Assoc. Dis. 21, 210 (2007).","journal-title":"Alzheimer Dis. Assoc. Dis."},{"key":"23418_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1017\/S1041610297004870","volume":"9","author":"JC Morris","year":"1997","unstructured":"Morris, J. C. Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the alzheimer type. Int. Psychogeriatr. 9, 173\u2013176 (1997).","journal-title":"Int. Psychogeriatr."},{"key":"23418_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/gps.5436","volume":"36","author":"HC Huang","year":"2021","unstructured":"Huang, H. C., Tseng, Y. M., Chen, Y. C., Chen, P. Y. & Chiu, H. Y. Diagnostic accuracy of the clinical dementia rating scale for detecting mild cognitive impairment and dementia: A bivariate meta-analysis. Int. J. Geriatr. Psychiatry. 36, 239\u2013251 (2021).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"23418_CR29","doi-asserted-by":"crossref","unstructured":"Cummings, J. et al. Exploring the relationship between patient-relevant outcomes and alzheimer\u2019s disease progression assessed using the clinical dementia rating scale: a systematic literature review. Front. Neurol. 14 (2023).","DOI":"10.3389\/fneur.2023.1208802"},{"key":"23418_CR30","doi-asserted-by":"publisher","first-page":"e01020","DOI":"10.1002\/brb3.1020","volume":"8","author":"I Beheshti","year":"2018","unstructured":"Beheshti, I., Maikusa, N. & Matsuda, H. The association between Brain-Age score (BAS) and traditional neuropsychological screening tools in alzheimer\u2019s disease. Brain Behav. 8, e01020 (2018).","journal-title":"Brain Behav."},{"key":"23418_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/JAD-215380","volume":"86","author":"WI Tseng","year":"2022","unstructured":"Tseng, W. I., Hsu, Y. C. & Kao, T. W. Brain age difference at baseline predicts clinical dementia rating change in approximately two years. J. Alzheimers Dis. 86, 613\u2013627. https:\/\/doi.org\/10.3233\/JAD-215380 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"23418_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.jocn.2010.12.019","volume":"18","author":"S Kim","year":"2011","unstructured":"Kim, S. et al. Voxel-based morphometric study of brain volume changes in patients with alzheimer\u2019s disease assessed according to the clinical dementia rating score. J. Clin. Neurosci. 18, 916\u2013921 (2011).","journal-title":"J. Clin. Neurosci."},{"key":"23418_CR33","doi-asserted-by":"publisher","unstructured":"LaMontagne, P. J. et al. OASIS-3: longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease. medrxiv Preprint (2019). https:\/\/doi.org\/10.1101\/2019.12.13.19014902 2019\u201312.","DOI":"10.1101\/2019.12.13.19014902"},{"key":"23418_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroimage.2013.04.127","volume":"80","author":"MF Glasser","year":"2013","unstructured":"Glasser, M. F. et al. The minimal preprocessing pipelines for the human connectome project. NeuroImage 80, 105\u2013124 (2013).","journal-title":"NeuroImage"},{"key":"23418_CR35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968\u2013980 (2006).","journal-title":"NeuroImage"},{"key":"23418_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341\u2013355 (2002).","journal-title":"Neuron"},{"key":"23418_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack, C. R. et al. Hypothetical model of dynamic biomarkers of the alzheimer\u2019s pathological cascade. Lancet Neurol. 9, 119\u2013128 (2010).","journal-title":"Lancet Neurol."},{"key":"23418_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2307\/2979746","volume":"60","author":"GU Yule","year":"1897","unstructured":"Yule, G. U. On the theory of correlation. J. Roy Statist Soc. 60, 812\u2013854 (1897).","journal-title":"J. Roy Statist Soc."},{"issue":"3-4","key":"23418_CR39","first-page":"329","volume":"3","author":"RA Fisher","year":"1924","unstructured":"FisherRA The distribution of the partial correlation coefficient. Metron 3 (3-4), 329\u2013332 (1924). (1924).","journal-title":"Metron"},{"key":"23418_CR40","unstructured":"Waliczek, T. M. A Primer on Partial Correlation Coefficientsp ED393882 (Governmental Editions, 1996)."},{"key":"23418_CR41","doi-asserted-by":"crossref","unstructured":"Cleophas, T. J. & Zwinderman, A. H. Regression Analysis in Medical Research, 2nd edition, pp 415\u2013421. Springer, Cham, Switzerland (2021).","DOI":"10.1007\/978-3-030-61394-5_24"},{"key":"23418_CR42","unstructured":"Snedecor, D. W. & Cochran, W. G. Statistical Methods (Iowa University, 1989)."},{"key":"23418_CR43","unstructured":"Sokal, R. R. & Rohlf, F. J. Bometry. Freeman, New York, NY (1994)."},{"key":"23418_CR44","unstructured":"Zar, J. H. Biostatistical Analysis, 2nd edition. Prentice-Hall, Englewood Cliffs, NJ (1984)."},{"key":"23418_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","volume":"52","author":"CR Jack","year":"1999","unstructured":"Jack, C. R. et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397\u20131397 (1999).","journal-title":"Neurology"},{"key":"23418_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(01)05408-3","volume":"358","author":"NC Fox","year":"2001","unstructured":"Fox, N. C. et al. Imaging of onset and progression of alzheimer\u2019s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358, 201\u2013205 (2001).","journal-title":"Lancet"},{"key":"23418_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JAD-142292","volume":"46","author":"R Migliaccio","year":"2015","unstructured":"Migliaccio, R. et al. Mapping the progression of atrophy in Early- and Late-Onset alzheimer\u2019s disease. J. Alzheimers Dis. 46, 351\u2013364 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"23418_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/WNL.0b013e31829d86e8","volume":"81","author":"GB Frisoni","year":"2013","unstructured":"Frisoni, G. B. et al. Imaging markers for alzheimer disease: which vs how. Neurology 81, 487\u2013500 (2013).","journal-title":"Neurology"},{"key":"23418_CR49","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/brain\/awn278","volume":"131","author":"LW de Jong","year":"2008","unstructured":"de Jong, L. W. et al. Strongly reduced volumes of putamen and thalamus in alzheimer\u2019s disease: an MRI study. Brain 131, 3277\u20133285 (2008).","journal-title":"Brain"},{"key":"23418_CR50","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.neurobiolaging.2010.05.002","volume":"31","author":"SK Madsen","year":"2010","unstructured":"Madsen, S. K. et al. 3D maps localize caudate nucleus atrophy in 400 alzheimer\u2019s disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol. Aging. 31, 1312\u20131325. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.002 (2010).","journal-title":"Neurobiol. Aging"},{"key":"23418_CR51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3233\/JAD-2010-100678","volume":"22","author":"J Fortea","year":"2010","unstructured":"Fortea, J. et al. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J. Alzheimers Dis. 22, 909\u2013922 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"23418_CR52","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1002\/hbm.22431","volume":"35","author":"X Tang","year":"2014","unstructured":"Tang, X., Holland, D., Dale, A. M., Younes, L. & Miller, M. I. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and alzheimer\u2019s disease: Detecting, quantifying, and predicting. Hum. Brain Mapp. 35, 3701\u20133725 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"23418_CR53","doi-asserted-by":"publisher","first-page":"123113","DOI":"10.1016\/j.jns.2024.123113","volume":"462","author":"S Na","year":"2024","unstructured":"Na, S., Kim, T., Song, I. U., Hong, Y. J. & Kim, S. H. Cortex-to-caudate volume ratio as a predictor of cognitive decline in alzheimer\u2019s disease and mild cognitive impairment. J. Neurol. Sci. 462, 123113. https:\/\/doi.org\/10.1016\/j.jns.2024.123113 (2024).","journal-title":"J. Neurol. Sci."},{"key":"23418_CR54","doi-asserted-by":"crossref","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U S A. 90, 1977\u20131981 (1993).","DOI":"10.1073\/pnas.90.5.1977"},{"key":"23418_CR55","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of Apolipoprotein E type 4 allele and the risk of alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"23418_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin, A. C. et al. ApoE in alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. Neurodegeneration. 17, 72 (2022).","journal-title":"Mol. Neurodegeneration"},{"key":"23418_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 396, 413\u2013446 (2020).","journal-title":"Lancet"},{"key":"23418_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","volume":"12","author":"S Emrani","year":"2020","unstructured":"Emrani, S., Arain, H. A., DeMarshall, C. & Nuriel, T. APOE4 is associated with cognitive and pathological heterogeneity in patients with alzheimer\u2019s disease: a systematic review. Alzheimers Res. Ther. 12, 141 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"23418_CR59","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1212\/WNL.59.5.746","volume":"59","author":"T Den Heijer","year":"2002","unstructured":"Den Heijer, T. et al. Hippocampal, amygdalar, and global brain atrophy in different Apolipoprotein E genotypes. Neurology 59, 746\u2013748 (2002).","journal-title":"Neurology"},{"key":"23418_CR60","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/brain\/awp007","volume":"132","author":"N Schuff","year":"2009","unstructured":"Schuff, N. et al. MRI of hippocampal volume loss in early alzheimer\u2019s disease in relation to ApoE genotype and biomarkers. Brain 132, 1067\u20131077 (2009).","journal-title":"Brain"},{"key":"23418_CR61","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray, M. E. et al. Neuropathologically defined subtypes of alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785\u2013796. https:\/\/doi.org\/10.1016\/S1474-4422(11)70156-9 (2011).","journal-title":"Lancet Neurol."},{"key":"23418_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/ene.15657","volume":"30","author":"G Forno","year":"2023","unstructured":"Forno, G. et al. The APOE4 effect: structural brain differences in alzheimer\u2019s disease according to the age at symptom onset. Eur. J. Neurol. 30, 597\u2013605 (2023).","journal-title":"Eur. J. Neurol."},{"key":"23418_CR63","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nicl.2017.08.014","volume":"16","author":"F Falahati","year":"2017","unstructured":"Falahati, F. et al. Monitoring disease progression in mild cognitive impairment: associations between atrophy patterns, cognition, APOE and amyloid. NeuroImage Clin. 16, 418\u2013428 (2017).","journal-title":"NeuroImage Clin."},{"key":"23418_CR64","doi-asserted-by":"publisher","first-page":"153331752110122","DOI":"10.1177\/15333175211012235","volume":"36","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Natale, G. & Clouston, S. Incidence of mild cognitive impairment, conversion to probable dementia, and mortality. Am. J. Alzheimers Dis. Other Demen. 36, 15333175211012235 (2021).","journal-title":"Am. J. Alzheimers Dis. Other Demen"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23418-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:03:16Z","timestamp":1763074996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23418"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23418-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39852"}}